BiotechTube

Cytogam

ApprovedRecruiting
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Cytomegalovirus (CMV) Infection

Conditions

Cytomegalovirus (CMV) Infection

Trial Timeline

Jun 26, 2025 → Dec 1, 2027

NCT ID
NCT07009548

About Cytogam

Cytogam is a approved stage product being developed by Kamada for Cytomegalovirus (CMV) Infection. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07009548. Target conditions include Cytomegalovirus (CMV) Infection.

Hype Score Breakdown

Clinical
30
Activity
20
Company
2
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT07009548ApprovedRecruiting

Competing Products

20 competing products in Cytomegalovirus (CMV) Infection

See all competitors
ProductCompanyStageHype Score
ASP0113 + PlaceboAstellas PharmaPhase 2
52
ASP0113 + PlaceboAstellas PharmaPhase 3
77
Letermovir oral granules + Letermovir tablet + Letermovir intravenousMerckPhase 2
52
Letermovir 240 mg Oral TabletMerckPhase 2
52
Letermovir tablet + Letermovir IVMerckPhase 3
77
LetermovirMerckPhase 1
33
LetermovirMerckApproved
85
Letermovir 480 MG [Prevymis]MerckPhase 2
52
V160 Low Dose IM + V160 Medium Dose IM + V160 High Dose IM + V160 Medium Dose plus Merck Aluminum Phosphate Adjuvant (MAPA) 225 µg /dose IM + V160 High Dose plus MAPA 225 µg /dose IM + V160 Maximum Dose IM + V160 Medium Dose IDMerckPhase 1
33
GanciclovirMerckPre-clinical
23
Letermovir + PlaceboMerckPhase 3
77
LetermovirMerckPhase 2
52
V160 + PlaceboMerckPhase 2
52
V160MerckPhase 1
33
LetermovirMerckPhase 3
77
LetermovirMerckPhase 3
77
Valganciclovir + GanciclovirRochePhase 3
77
Zidovudine + Didanosine + GanciclovirRochePhase 1
33
ValganciclovirRochePre-clinical
23
Foscarnet sodium + GanciclovirRochePhase 1
33

Other Products from Kamada

Cytomegalovirus Immune Globulin Intravenous (Human) monthly for three monthsApproved
77
KamRAB - HRIGPhase 3
69
Alpha 1-Antitrypsin + PlaceboPhase 3
69
Active rabies vaccine (US-FDA approved)Phase 2/3
57
GLASSIA + methylprednisolone or equivalent steroid + AlbuminPhase 2/3
57